Advertisement

Zydus's Covid drug Virafin gets nod for emergency use

Zydus Cadila's Covid drug Virafin has received emergency use approval from the Drug Controller General of India (DCGI).

At a time when India's healthcare infrastructure is reeling under tremendous pressure, Virafin is being presented as a drug that can reduce the need for oxygen support and improve recovery time among moderate cases of Covid-19.

Read More

VIDEOS FROM OTHER SECTIONS

LATEST VIDEOS

India-US trade deal: Win-win or one-sided deal?

A day after US President Donald Trump on Monday announced the landmark India-US trade deal and that he would reduce reciprocal tariffs from 25 per cent to 18 per cent, a massive political war has erupted in Delhi.

advertisement